Zhejiang Tongxuan Medical Technology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zhejiang Tongxuan Medical Technology - overview
Established
2020
Location
Taizhou, Zhejiang, China
Primary Industry
Medical Devices & Equipment
About
Established in 2020 and base in Taizhou, China, Zhejiang Tongxuan Medical Technology operates as a medical device manufacturer dedicated to providing balloon interventional medical devices. It cooperates with CR Pharmaceutical Commercial Group Co. , Ltd. , Sinopharm Group Co.
, Ltd. , Shanghai Pharmaceuticals, and other companies. In January 2024, Tongxuan Medical closed strategic investment. In August 2025, Zhejiang Tongxuan Medical Technology closed a series A+ funding from new investor Qiming Venture Partners.
The company mainly provides medical devices in the field of balloon dilation. The main product is prostate expansion catheter and balloon pressure pump. The products have been used in the field of urology. The company also uses balloon technology to develop new products, which covering segments such as urology, digestion, obstetrics and gynecology, interventional, intracardiac, orthopedics, and facial features.
The company will increase hospital penetration coverage of existing products and achieve in-hospital sales of new products.
Current Investors
Lanwan Venture Capital, Minsheng Securities Investment, Qiming Venture Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Therapeutic Devices
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.